FGC
HZNP

Financial Gravity Companies’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Financial Gravity Companies’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$1K Buy
+63
New +$1.24K ﹤0.01% 1328
2018
Q1 		$1K Buy
89
+23
+35% +$340 ﹤0.01% 1352
2017
Q4 		$1K Buy
+66
New +$927 ﹤0.01% 1306

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Financial Gravity Companies's HZNP Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2018: 63 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1328 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in HZNP as recently as Q1 2018.

Financial Gravity Companies first reported a position in HZNP in Q4 2017 and has held it in 3 quarters since. 239 funds tracked by Wall St. Rank hold HZNP as of Q4 2018.

  • Financial Gravity Companies held 63 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $1K as of Q4 2018.
  • Horizon Therapeutics Public Limited Company Ordinary Shares was a new Financial Gravity Companies position in Q4 2018.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1328 holding.
  • Financial Gravity Companies first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2017 and has held it in 3 quarters since.
  • 239 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.